Back

Discussion – Pre-diabetes and metabolic syndrome: what are they and what do they mean for cardiovascular risk

13 April 2023 (16:13 - 16:25)
Organised by:
Congress Presentation Part of: Pre-diabetes and metabolic syndrome: what are they and what do they mean for cardiovascular risk Diabetes and the Heart EAPC Premium Access ESC Preventive Cardiology 2023

4 More presentations in this session

Presentation thumbnail
Prediabetes – why is it relevant for cardiovascular and neurological disease risk?
Professor C. Stehouwer (Maastricht, NL)
Slides Video
Presentation thumbnail
Pre-diabetes: when and how to act to delay CV risk progression
Unknown S. Kabisch (Berlin, DE)
Slides Video
Presentation thumbnail
Is bempedoic acid better than statins to avoid new-onset diabetes?
Professor M. Banach (Lodz, PL)
Slides Video
Presentation thumbnail
Patients with (pre-)diabetes and HFpEF : how do we treat phenogroups?
Doctor A. Alogna (Berlin, DE)
Slides Video

Access the full session

Session thumbnail
Pre-diabetes and metabolic syndrome: what are they and what do they mean for cardiovascular risk
Video

The Event

Event poster

ESC Preventive Cardiology 2023

13 April 2023 16:13 CET
You may be interested in
thumbnail
Congress Presentation
Pre-diabetes: from early cardiovascular risk detection to effective action - discussion
23 April 2026
thumbnail
Congress Presentation
Lifestyle interventions to effectively reduce cardiovascular risk in the prediabetic patient: an illusion?
26 August 2022
thumbnail
Congress Presentation
Panel discussion and Q&A.
28 August 2022
thumbnail
Congress Session
Metabolic drivers of cardiovascular disease
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources